{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.1444.3.140",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2021-03-06T01:00:16.000-05:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.140",
  "version": "20210306",
  "name": "Ondansetron Oral",
  "status": "active",
  "date": "2021-03-06T01:00:16-05:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "concept": [
          {
            "code": "104894",
            "display": "ondansetron 4 MG Disintegrating Oral Tablet"
          },
          {
            "code": "198052",
            "display": "ondansetron 4 MG Oral Tablet"
          },
          {
            "code": "312084",
            "display": "ondansetron 24 MG Oral Tablet"
          },
          {
            "code": "312085",
            "display": "ondansetron 0.8 MG/ML Oral Solution"
          },
          {
            "code": "312086",
            "display": "ondansetron 8 MG Oral Tablet"
          },
          {
            "code": "312087",
            "display": "ondansetron 8 MG Disintegrating Oral Tablet"
          },
          {
            "code": "692695",
            "display": "ondansetron 16 MG Oral Tablet"
          },
          {
            "code": "998028",
            "display": "ondansetron 8 MG Oral Film"
          },
          {
            "code": "998033",
            "display": "ondansetron 4 MG Oral Film"
          }
        ]
      }
    ]
  }
}